MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Apraclonidine in blepharospasm

    J. Jankovic, D. Vijayakumar, S. Wijemanne (Houston, TX, USA)

    Objective: To describe improvement in blepharospasm with apraclonidine. Background: Blepharospasm is a focal dystonia involving chiefly the orbicularis oculi muscle resulting in involuntary sustained eyelid…
  • 2016 International Congress

    Experience of pallidal deep brain stimulation (DBS) in dystonia at a tertiary care centre in India

    D. Srinivas, R. Yadav, K. Jhunjhunwala, P. Pal (Bangalore, India)

    Objective: The therapeutic role of Deep Brain Stimulation (DBS) has expanded for severe primary and secondary dystonias. Till date, only a few centres in India…
  • 2016 International Congress

    Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

    M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To evaluate botulinum toxin A (BoNT-A) effectiveness on network in sensorimotor circuits. Background: Involvement of many cerebellar structures, such basal ganglia, thalamus, cerebellum, premotor…
  • 2016 International Congress

    AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries

    R. Trosch, V.P. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: To explore national differences in the use of abobotulinumtoxinA (ABO) in the management of cervical dystonia (CD). Background: Botulinum toxin injections (including ABO) are…
  • 2016 International Congress

    International differences in the baseline characteristics and clinical management of cervical dystonia patients presenting for botulinum toxin treatment in routine practice

    D. Charles, T.M. Chung, V.P. Misra, C. Colosimo, S. Om, P. Maisonobe (Nashville, TN, USA)

    Objective: To characterise the demographic and clinical characteristics of cervical dystonia (CD) patients presenting for routine treatment with botulinum neurotoxin-A (BoNT-A) across different regions. Background:…
  • 2016 International Congress

    Sensory gating and inhibition in dystonia

    E. Antelmi, R. Erro, L. Rocchi, R. Liguori, M. Tinazzi, J. Rothwell, K. Bhatia (Bologna, Italy)

    Objective: By performing an extensive evaluation of neurophysiological measurements accounting for inhibitory mechanisms within the S1, we aim to find if a central nervous system…
  • 2016 International Congress

    Improvement of post-stroke fixed dystonia of upper and lower limb following DBS of internal capsule: Report of two cases

    G. Messina, V. Levi, R. Cordella, I. Dones, A. Franzini (Milan, Italy)

    Objective: To evaluate the therapeutic effect of chronic stimulation of posterior limb of the internal capsule in two subjects affected by fixed dystonia of the…
  • 2016 International Congress

    DYT2 dystonia – Too rare to be found?

    V. Dobricic, N. Kresojevic, A. Marjanovic, A. Tomic, M. Svetel, I. Novakovic, V. Kostic (Belgrade, Serbia)

    Objective: To estimate the frequency of HPCA mutations in Serbian cohort with dystonia. Background: Recently the HPCA gene has been reported as the first putative…
  • 2016 International Congress

    Digitally captured Archimedes spiral indices correlate with clinical assessment of dystonia severity

    J.B. Ratliff, A. Mirallave, R. Ortega, A. Glickman, Q. Yu, D. Raymond, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To determine whether digitized spiral analysis captures severity of dystonia in comparison to motor scores from the clinical gold standard, the Burke-Fahn-Marsden rating scale…
  • 2016 International Congress

    Exome sequencing reveals homozygous mutations in SACS, ATCAY, and MCOLN1 in three Pakistani families with complex dystonia

    H. Manzoor, N. Brüggemann, F. Hinrichs, H.M.J. Hussain, M. Wajid, T. Bäumer, A. Münchau, S. Naz, K. Lohmann (Lahore, Pakistan)

    Objective: To elucidate the genetic cause in Pakistani families with recessively inherited disorders with dystonic features. Background: Dystonia is a movement disorder characterized by sustained…
  • « Previous Page
  • 1
  • …
  • 1683
  • 1684
  • 1685
  • 1686
  • 1687
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley